These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 26608025)
1. Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant. Kim JI; Park TE; Maharjan S; Li HS; Lee HB; Kim IS; Piao D; Lee JY; Cho CS; Bok JD; Hong ZS; Kang SK; Choi YJ BMC Immunol; 2015 Nov; 16():71. PubMed ID: 26608025 [TBL] [Abstract][Full Text] [Related]
2. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization. Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814 [TBL] [Abstract][Full Text] [Related]
3. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis. Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964 [TBL] [Abstract][Full Text] [Related]
4. Postbiotic-based recombinant receptor activator of NF-κB ligand enhanced oral vaccine efficiency in chicken. Xuan B; Park J; Choi S; Kim EB Appl Microbiol Biotechnol; 2024 Jun; 108(1):397. PubMed ID: 38922350 [TBL] [Abstract][Full Text] [Related]
5. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173 [TBL] [Abstract][Full Text] [Related]
6. Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum. Maharjan S; Singh B; Jiang T; Yoon SY; Li HS; Kim G; Gu MJ; Kim SJ; Park OJ; Han SH; Kang SK; Yun CH; Choi YJ; Cho CS Biomaterials; 2016 Apr; 84():286-300. PubMed ID: 26851393 [TBL] [Abstract][Full Text] [Related]
7. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo. Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479 [TBL] [Abstract][Full Text] [Related]
8. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. Williamson E; Bilsborough JM; Viney JL J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151 [TBL] [Abstract][Full Text] [Related]
9. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut. Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408 [TBL] [Abstract][Full Text] [Related]
10. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. Knoop KA; Kumar N; Butler BR; Sakthivel SK; Taylor RT; Nochi T; Akiba H; Yagita H; Kiyono H; Williams IR J Immunol; 2009 Nov; 183(9):5738-47. PubMed ID: 19828638 [TBL] [Abstract][Full Text] [Related]
11. c-Rel is dispensable for the differentiation and functional maturation of M cells in the follicle-associated epithelium. Sehgal A; Kobayashi A; Donaldson DS; Mabbott NA Immunobiology; 2017 Feb; 222(2):316-326. PubMed ID: 27663963 [TBL] [Abstract][Full Text] [Related]
12. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Brayden DJ; Jepson MA; Baird AW Drug Discov Today; 2005 Sep; 10(17):1145-57. PubMed ID: 16182207 [TBL] [Abstract][Full Text] [Related]
14. Towards targeting strategies for oral immunization--identification of marker antigens in rat M cells. Rautenberg K; Cichon C; Schmidt MA Behring Inst Mitt; 1997 Feb; (98):361-75. PubMed ID: 9382761 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii. Lee P; Abdul-Wahid A; Faubert GM Microbes Infect; 2009 Jan; 11(1):20-8. PubMed ID: 18992359 [TBL] [Abstract][Full Text] [Related]
16. Starch microparticles as a vaccine adjuvant: only uptake in Peyer's patches decides the profile of the immune response. Stertman L; Lundgren E; Sjöholm I Vaccine; 2006 Apr; 24(17):3661-8. PubMed ID: 16513226 [TBL] [Abstract][Full Text] [Related]
17. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Lei H; Peng X; Jiao H; Zhao D; Ouyang J Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406 [TBL] [Abstract][Full Text] [Related]
18. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. Corr SC; Gahan CC; Hill C FEMS Immunol Med Microbiol; 2008 Jan; 52(1):2-12. PubMed ID: 18081850 [TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. Misumi S; Masuyama M; Takamune N; Nakayama D; Mitsumata R; Matsumoto H; Urata N; Takahashi Y; Muneoka A; Sukamoto T; Fukuzaki K; Shoji S J Immunol; 2009 May; 182(10):6061-70. PubMed ID: 19414757 [TBL] [Abstract][Full Text] [Related]
20. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mabbott NA; Donaldson DS; Ohno H; Williams IR; Mahajan A Mucosal Immunol; 2013 Jul; 6(4):666-77. PubMed ID: 23695511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]